Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline forCYP2D6andCYP2C19Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 98, Issue 2, Pages 127-134
Publisher
Wiley
Online
2015-05-14
DOI
10.1002/cpt.147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Comparison of the Risk of QT Prolongation Among SSRIs
- (2014) Kylee A. Funk et al. ANNALS OF PHARMACOTHERAPY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
- (2014) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Emergency Department Visits by Adults for Psychiatric Medication Adverse Events
- (2014) Lee M. Hampton et al. JAMA Psychiatry
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
- (2013) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Estimation of CYP2D6*10 genotypes on citalopram disposition in Chinese subjects by population pharmacokinetic assay
- (2013) B. Chen et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Genetic differences in cytochrome P450 enzymes and antidepressant treatment response
- (2013) Karen Hodgson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions
- (2012) R. Mandrioli et al. CURRENT MEDICINAL CHEMISTRY
- Genetics and Personalized Medicine in Antidepressant Treatment
- (2012) Katarina Gvozdic et al. CURRENT PHARMACEUTICAL DESIGN
- Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
- (2012) J C Stingl et al. MOLECULAR PSYCHIATRY
- CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP
- (2011) Patricia Huezo-Diaz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
- (2011) C. Hiemke et al. PHARMACOPSYCHIATRY
- Venlafaxine or a second SSRI: Switching after treatment failure with an SSRI among depressed inpatients: A retrospective analysis
- (2011) Yoram Barak et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
- (2010) Dirk Sibbing et al. CIRCULATION
- Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker
- (2009) L. Noehr-Jensen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluation of the influence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopram
- (2009) Salvador Fudio et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients
- (2008) I. Rudberg et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Paroxetine
- (2008) Siu Wa Tang et al. EXPERT OPINION ON PHARMACOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started